Index
-
Market Cap
10.26B
Enterprise Value
13.48B
Income
337.20M
Sales
6.64B
Book/sh
8.61
Cash/sh
0.69
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
13500
IPO
May 17, 2019
P/E
30.52
Forward P/E
17.04
PEG
6.58
P/S
1.55
P/B
1.76
P/C
22.10
P/FCF
23.36
EV/EBITDA
13.93
EV/Sales
2.03
Quick Ratio
1.27
Current Ratio
1.89
Debt/Eq
0.63
LT Debt/Eq
0.63
Option/Short
Yes / Yes
EPS (ttm)
0.50
EPS next Y
0.89
EPS next Q
0.22
EPS this Y
-9.22%
EPS next Y
8.77%
EPS next 5Y
2.59%
EPS past 3/5Y
- -
Sales past 3/5Y
-4.46% 0.49%
EPS Y/Y TTM
517.17%
Sales Y/Y TTM
0.92%
EPS Q/Q
128.61%
Sales Q/Q
4.59%
Insider Own
3.07%
Insider Trans
0.05%
Inst Own
102.93%
Inst Trans
2.06%
ROA
2.89%
ROE
5.91%
ROIC
3.56%
Gross Margin
30.45%
Oper. Margin
8.27%
Profit Margin
5.08%
SMA20
-6.93%
SMA50
-2.81%
SMA200
34.42%
Trades
Shs Outstand
677.70M
Shs Float
656.81M
52W High
17.45 -13.24%
52W Low
7.26 108.40%
Volatility
4.20% 3.28%
ATR (14)
0.55
RSI (14)
37.63
Beta
0.95
Rel Volume
0.00
Avg Volume
8.66M
Volume
0
Perf Week
-9.23%
Perf Month
-1.37%
Perf Quarter
11.41%
Perf Half Y
82.19%
Perf YTD
32.11%
Perf Year
30.74%
Perf 3Y
-17.58%
Perf 5Y
-60.35%
Perf 10Y
-
Prev Close
15.14
Price
15.14
Change %
0.00%
Analysts 16 incl. previous ratings
Rating Distribution 1 Buy · 13 Hold · 2 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Sep 09, 2026 Initiated U UBS
Neutral $16 +5.7% Jul 29, 2026 Upgrade J Jefferies
Underperform → Hold $13 -14.1% Jun 26, 2026 Resumed B Bernstein
Mkt Perform $10.50 -30.6% Jun 02, 2026 Resumed W Wolfe Research
Underperform $7 -53.8% May 15, 2026 Resumed R RBC Capital Mkts
Sector Perform $9 -40.6% Mar 06, 2026 Downgrade B Barclays
Equal Weight → Underweight $8.50 -43.9% Jan 05, 2026 Downgrade E Evercore ISI
Outperform → In-line $12 -20.7% Dec 17, 2025 Downgrade J Jefferies
Hold → Underperform $9 -40.6% Dec 15, 2025 Downgrade B BofA Securities
Buy → Neutral $13 -14.1% Nov 04, 2025 Downgrade R Raymond James
Outperform → Mkt Perform Oct 30, 2025 Downgrade J JP Morgan
Overweight → Neutral $12 -20.7% Oct 30, 2025 Downgrade B Barclays
Overweight → Equal Weight $12 -20.7% Aug 01, 2025 Downgrade J Jefferies
Buy → Hold Apr 29, 2025 Downgrade G Goldman
Buy → Neutral $14 -7.5% Apr 28, 2025 Downgrade T TD Cowen
Buy → Hold $15.50 +2.4% Apr 28, 2025 Downgrade S Stifel
Buy → Hold $14 -7.5% Apr 28, 2025 Downgrade M Morgan Stanley
Overweight → Equal-Weight Jan 17, 2025 Downgrade U UBS
Buy → Neutral $29 → $25 +65.1% Aug 28, 2024 Initiated W Wells Fargo
Overweight $30 +98.2% Jul 10, 2024 Downgrade C Citigroup
Buy → Neutral $30 → $23 +51.9%
Show Previous Ratings
Oct-28-26 10:50AM
06:05AM
Oct-26-26 08:05AM
Oct-01-26 06:05AM
Sep-21-26 06:05AM
02:29PM
Loading…
Jul-30-26 02:29PM
Jul-29-26 03:02PM
06:05AM
Jul-14-26 08:05AM
Jul-01-26 08:05AM
May-19-26 06:05AM
Apr-29-26 08:54AM
06:05AM
Apr-23-26 05:05PM
Apr-21-26 08:05AM
09:47AM
Loading…
Apr-16-26 09:47AM
Apr-13-26 08:05AM
Apr-03-26 08:05AM
Apr-01-26 08:00AM
Mar-05-26 04:57AM
Mar-04-26 12:41PM
Mar-02-26 05:19AM
Feb-27-26 02:45PM
Feb-26-26 09:26AM
Feb-18-26 04:36AM
04:30AM
12:36AM
Feb-17-26 01:43AM
Feb-14-26 01:25AM
Feb-12-26 10:41AM
12:33AM
Loading…
12:33AM
Feb-11-26 02:23PM
02:01PM
01:50PM
01:42PM
09:30AM
07:15AM
06:17AM
06:05AM
Feb-09-26 10:08PM
Feb-06-26 09:40AM
Feb-05-26 11:40AM
Feb-04-26 07:40AM
Feb-01-26 09:21AM
Jan-12-26 08:05AM
Jan-08-26 08:29AM
Jan-05-26 08:05AM
Jan-02-26 09:44AM
Jan-01-26 11:04PM
Dec-26-25 09:00AM
Dec-25-25 11:50PM
Dec-24-25 04:32AM
Dec-23-25 09:00AM
Dec-22-25 03:15AM
Dec-18-25 10:31PM
08:05AM
Dec-12-25 09:45AM
Dec-11-25 07:52AM
Dec-10-25 01:06PM
Dec-09-25 08:42AM
Dec-08-25 06:13AM
Dec-04-25 04:15PM
Nov-25-25 08:05AM
Nov-19-25 08:05AM
Nov-11-25 04:30AM
Nov-10-25 08:30AM
Nov-05-25 12:36AM
Nov-03-25 02:43AM
Oct-31-25 05:00PM
03:20PM
Oct-30-25 02:02PM
11:26AM
08:05AM
01:33AM
Oct-29-25 03:46PM
09:30AM
07:15AM
06:16AM
06:05AM
Oct-27-25 11:05PM
11:44AM
Oct-24-25 08:07AM
Oct-23-25 08:05AM
Oct-22-25 10:00AM
Oct-21-25 01:41PM
12:04AM
Oct-17-25 12:23PM
Oct-15-25 08:05AM
Oct-13-25 04:05PM
Oct-03-25 01:05PM
08:05AM
Oct-02-25 11:35PM
Oct-01-25 05:34PM
08:05AM
Sep-19-25 09:05AM
Sep-03-25 02:45PM
Aug-27-25 04:32PM
Aug-26-25 12:37AM
Aug-19-25 08:00AM
(Investor's Business Daily)
Aug-13-25 05:51PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LUCIER GREGORY T Director May 08 '26 Buy 8.32 10,000 83,200 60,000 May 11 04:39 PM Dingemans Simon Director May 01 '26 Buy 8.14 25,000 203,500 25,000 May 05 07:44 PM MEHRA SANJEEV K Director Mar 10 '26 Buy 8.01 125,000 1,001,250 475,000 Mar 11 05:10 PM LUCIER GREGORY T Director Feb 19 '26 Buy 9.16 50,000 458,000 50,000 Feb 23 08:53 PM SUMME GREGORY L Director Feb 12 '26 Buy 9.40 100,000 940,000 400,000 Feb 12 05:24 PM MEHRA SANJEEV K Director Dec 05 '25 Buy 11.09 350,000 3,881,500 350,000 Dec 09 05:11 PM Ligner Emmanuel President and CEO Nov 17 '25 Buy 11.35 87,500 993,125 283,424 Nov 17 05:45 PM
Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the Laboratory Solutions segment and Bioscience Production. The Laboratory Solutions segment focuses on research, diagnostic, and quality control workflows. The Bioscience Production segment focuses on high-purity materials for bioprocessing and medical technologies. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.
President Mr. Emmanuel Ligner
Executive VP Mr. Claudius O. Sokenu
President of Laboratory Solutions Mr. Corey D. Walker
Executive Vice President of Bioscience Production Mr. Benoit Gourdier
Executive VP & CFO Mr. Todd W. Garner CPA